Response to and toxicity of gemcitabine for recurrent ovarian cancer according to number of previous chemotherapy regimens-Reference-Cited by-同舟云学术

Response to and toxicity of gemcitabine for recurrent ovarian cancer according to number of previous chemotherapy regimens

Published:2016-12-09 Issue:2 Volume:43 Page:358-364
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Takei Yuji¹,Takahashi Yoshifumi¹,Machida Shizuo¹,Taneichi Akiyo¹,Takahashi Suzuyo¹,Nagashima Tomomi¹,Morisawa Hiroyuki¹,Saga Yasushi¹,Matsubara Shigeki¹,Fujiwara Hiroyuki¹

Affiliation:

1. Department of Obstetrics and Gynecology; Jichi Medical University; Tochigi Japan

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jog.13203/fullpdf

Reference22 articles.

1. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer;Heintz;Int J Gynaecol Obstet,2006

2. Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer;Mutch;J Clin Oncol,2007

3. Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer;Ferrandina;J Clin Oncol,2008

4. Long-term survival in a phase III, randomised study of topotecan versus paclitaxel in advanced epithelial ovarian carcinoma;Bokkel;Ann Oncol,2004

5. Recurrent epithelial ovarian carcinoma: A randomized phase III study of pegylated liposomal doxorubicin versus topotecan;Gordon;J Clin Oncol,2001

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS, Redox Regulation, and Anticancer Therapy;Redox Regulation and Therapeutic Approaches in Cancer;2023

2. Efficacy of non‑platinum chemotherapy in platinum‑resistant ovarian cancer: a meta‑analysis;Malignant tumours;2022-04-08

3. Inhibition of Proliferation in Ovarian Cancer Cell Line (PA-1) by the Action of Green Compound “Betanin”;Applied Biochemistry and Biotechnology;2021-11-11

4. Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma;Frontiers in Oncology;2021-07-21

5. Efficacy and toxicity of pegylated liposomal doxorubicin as therapy for recurrent ovarian cancer in relation to the number of previous chemotherapy regimens: Comparison with gemcitabine;Journal of Obstetrics and Gynaecology Research;2020-11-04